| 5.56 -0.01 (-0.18%) | 04-24 12:35 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.2  |
1-year : | 7.82 |
| Resists | First : | 6.16 |
Second : | 6.69 |
| Pivot price | 5.75 |
|||
| Supports | First : | 5.3 | Second : | 4.4 |
| MAs | MA(5) : | 5.53 |
MA(20) : | 5.77 |
| MA(100) : | 5.18 |
MA(250) : | 5.48 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 28.9 |
D(3) : | 26.4 |
| RSI | RSI(14): 44.8 |
|||
| 52-week | High : | 8.22 | Low : | 3.65 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BTMD ] has closed above bottom band by 28.2%. Bollinger Bands are 30.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.81 - 5.83 | 5.83 - 5.86 |
| Low: | 5.42 - 5.45 | 5.45 - 5.47 |
| Close: | 5.53 - 5.57 | 5.57 - 5.61 |
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Sun, 14 Apr 2024
biote Corp. (NASDAQ:BTMD) Short Interest Up 16.4% in March - MarketBeat
Tue, 09 Apr 2024
Financial Analysis: biote (NASDAQ:BTMD) vs. MediWound (NASDAQ:MDWD) - Defense World
Mon, 08 Apr 2024
biote Corp. Forecasted to Post Q1 2024 Earnings of ($0.01) Per Share (NASDAQ:BTMD) - MarketBeat
Wed, 13 Mar 2024
Jefferies raises Biote stock target to $8.24, maintains buy rating - Investing.com
Tue, 12 Mar 2024
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript - Seeking Alpha
Tue, 12 Mar 2024
Biote Corp (BTMD) Reports Growth Amidst Challenges in Q4 and Full Year 2023 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
PNK
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 36 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 9 (%) |
| Held by Institutions | 45.1 (%) |
| Shares Short | 878 (K) |
| Shares Short P.Month | 586 (K) |
| EPS | 0.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.87 |
| Profit Margin | 1.7 % |
| Operating Margin | 20.9 % |
| Return on Assets (ttm) | 18.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 2.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.11 |
| EBITDA (p.s.) | 1.09 |
| Qtrly Earnings Growth | 341.7 % |
| Operating Cash Flow | 27 (M) |
| Levered Free Cash Flow | 23 (M) |
| PE Ratio | 42.92 |
| PEG Ratio | 0 |
| Price to Book value | -6.49 |
| Price to Sales | 1.09 |
| Price to Cash Flow | 7.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|